| Vision Optique | |
|
2997 Highway 190, Mandeville, LA 70471-3298 | |
| (985) 727-9948 | |
| (985) 237-6008 |
| Full Name | Vision Optique |
|---|---|
| Type | Facility |
| Speciality | Technician/technologist - Optician |
| Location | 2997 Highway 190, Mandeville, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134152408 | NPI | - | NPPES |
| 1943436 | Medicaid | LA | |
| 1398969 | Medicaid | LA |
| Provider Name | Glenn M Coullard |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346209236 PECOS PAC ID: 3577577444 Enrollment ID: I20070219000588 |
News Archive
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.
Today, CLC bio, the world's leading bioinformatics solution provider, announced a partnership with Isilon® Systems, Inc. which will help the life science community eliminate some of the toughest workflow bottlenecks when working with high-throughput sequencing data: Analysis and storage.
› Verified 3 days ago
| Provider Name | Stephen Borchers |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1043403439 PECOS PAC ID: 0941393995 Enrollment ID: I20070906000618 |
News Archive
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.
Today, CLC bio, the world's leading bioinformatics solution provider, announced a partnership with Isilon® Systems, Inc. which will help the life science community eliminate some of the toughest workflow bottlenecks when working with high-throughput sequencing data: Analysis and storage.
› Verified 3 days ago
| Provider Name | Janie Tran |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609122217 PECOS PAC ID: 1355575648 Enrollment ID: I20130927000112 |
News Archive
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.
Today, CLC bio, the world's leading bioinformatics solution provider, announced a partnership with Isilon® Systems, Inc. which will help the life science community eliminate some of the toughest workflow bottlenecks when working with high-throughput sequencing data: Analysis and storage.
› Verified 3 days ago
| Provider Name | Brian J Bratcher |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1407238777 PECOS PAC ID: 5597071449 Enrollment ID: I20150909000092 |
News Archive
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.
Today, CLC bio, the world's leading bioinformatics solution provider, announced a partnership with Isilon® Systems, Inc. which will help the life science community eliminate some of the toughest workflow bottlenecks when working with high-throughput sequencing data: Analysis and storage.
› Verified 3 days ago
| Provider Name | Greyssy L Melgar |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346792918 PECOS PAC ID: 6002196631 Enrollment ID: I20161216001242 |
News Archive
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.
Today, CLC bio, the world's leading bioinformatics solution provider, announced a partnership with Isilon® Systems, Inc. which will help the life science community eliminate some of the toughest workflow bottlenecks when working with high-throughput sequencing data: Analysis and storage.
› Verified 3 days ago
| Provider Name | Shaista Vally |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1619343712 PECOS PAC ID: 3173830734 Enrollment ID: I20190909000188 |
News Archive
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.
Today, CLC bio, the world's leading bioinformatics solution provider, announced a partnership with Isilon® Systems, Inc. which will help the life science community eliminate some of the toughest workflow bottlenecks when working with high-throughput sequencing data: Analysis and storage.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vision Optique Po Box 1950, Mandeville, LA 70470-1950 Ph: (985) 727-9948 | Vision Optique 2997 Highway 190, Mandeville, LA 70471-3298 Ph: (985) 727-9948 |
News Archive
Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis - on plastic transparency sheets or simple paper - to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.
Keryx Biopharmaceuticals, Inc. reported today that the Phase 3 "X-PECT" clinical trial evaluating perifosine (KRX-0401) + capecitabine (Xeloda) in patients with refractory advanced colorectal cancer did not meet the primary endpoint of improving overall survival versus capecitabine + placebo.
Chest compressions before defibrillation in patients with sudden cardiac arrest is equally successful as immediate treatment with an electrical defibrillator, according to a new study by the University of Michigan Health System.
Today, CLC bio, the world's leading bioinformatics solution provider, announced a partnership with Isilon® Systems, Inc. which will help the life science community eliminate some of the toughest workflow bottlenecks when working with high-throughput sequencing data: Analysis and storage.
› Verified 3 days ago